Andere Sprachen Nemaura Medical Inc.

Aktien

A2PWNG

US6404422080

NMRD

Verzögert OTC Markets Andere Börsenplätze 16:23:22 14.05.2024			% 5 Tage	% 1. Jan.
0,0339 ^USD	+8,87 %		+1,80 %	-84,52 %

10.04.	Nemaura Medical Inc. kündigt Änderungen im Vorstand an	CI
12.02.	Nemaura Medical Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nemaura Medical : Certificate of Incorporation/Bylaws - Form 8-K	22.04.
Nemaura Medical Inc. Announces Board Changes	10.04.
Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12.02.
Nemaura Medical Inc.(OTCPK:NMRD) dropped from S&P TMI Index	09.01.
Nemaura Medical Inc. - Important Update on Listing Status and Strategic Direction	04.01.
Nemaura Medical Inc.(OTCPK:NMRD) dropped from NASDAQ Composite Index	04.01.
Important Update on Listing Status and Strategic Direction	03.01.
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision	13.12.
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth	21.11.
Nemaura Medical Rolls Out Metabolic Health Program in UK	14.11.
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	14.11.
Nemaura Medical Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	14.11.
Nemaura Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13.11.
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update	13.11.
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.	26.09.23
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference	18.09.23
Nemaura Medical Says Nasdaq Listing Standards Probably Won't Be Met by Deadline	14.09.23
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process	14.09.23
Top Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)	14.09.23
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program	13.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nemaura Medical Inc.

Aktien

A2PWNG

US6404422080

NMRD

Andere Sprachen

Filter